Doyle LA, Sepehr GJ, Hamilton MJ, et al
Gastrointestinal protection: Consistent with its origins in gastric juice protein, BPC-157 has demonstrated protective and healing effects on gastrointestinal mucosa, including in models of inflammatory bowel disease, ulcers, and esophageal damage (5)
Safety, Eligibility, and When to Seek More Intensive Screening Both platforms screen for GLP-1 contraindications: personal or family history of medullary thyroid cancer, multiple endocrine neoplasia type 2, severe pancreatitis, and severe kidney disease
In addition, research indicates peptide therapy can help combat chronic fatigue, fibromyalgia, anxiety, and depression
A person may also react to an inactive ingredient used in the capsule